These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31270301)

  • 1. Telemetered common marmosets is useful for the assessment of electrocardiogram parameters changes induced by multiple cardiac ion channel inhibitors.
    Watanabe K; Tsubouchi T; Yamada T; Hinoi E; Miyawaki I
    J Toxicol Sci; 2019; 44(7):441-457. PubMed ID: 31270301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of drug-induced QT interval prolongation in telemetered common marmosets.
    Tabo M; Hara T; Sone S; Shishido N; Kuramoto S; Nakano K; Onodera H; Kimura K; Kobayashi K
    J Toxicol Sci; 2008 Aug; 33(3):315-25. PubMed ID: 18670163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment.
    Cros C; Skinner M; Moors J; Lainee P; Valentin JP
    Toxicol Appl Pharmacol; 2012 Dec; 265(2):200-8. PubMed ID: 23073507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological characterization of electrocardiogram PR and QRS intervals in conscious telemetered rats.
    Adeyemi O; Parker N; Pointon A; Rolf M
    J Pharmacol Toxicol Methods; 2020; 102():106679. PubMed ID: 32014539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys.
    Ohmura T; Chachin M; Tarui S; Nagakura A; Igarashi T; Ikeda H; Ikegami K; Kitagawa H; Uchida S
    Eur J Pharmacol; 1999 Aug; 378(2):169-75. PubMed ID: 10478629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterisation of electrocardiogram J-T
    Nogawa H; Muraki Y; Kawai T; Kuninishi Y
    Eur J Pharmacol; 2022 Jul; 927():175065. PubMed ID: 35640715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
    Sällström J; Al-Saffar A; Pehrson R
    J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of corrected JT-peak (JTpc) and Tpeak-to-Tend (TpTec) as proarrhythmia biomarkers in non-human primates: Outcome from a HESI consortium.
    Boulay E; Authier S; Bartko T; Greiter-Wilke A; Leishman D; Li D; Nichols JV; Pierson J; Rossman EI; Valentin JP; Vicente J; Walisser J; Troncy E; Wisialowski TA
    J Pharmacol Toxicol Methods; 2024; 129():107543. PubMed ID: 39019200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative haemodynamic effects of verapamil, flecainide, amiodarone and sotalol in the conscious rabbit.
    Twidale N; Roberts-Thomson P; McRitchie RJ; Chalmers JP
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):179-88. PubMed ID: 8076419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKPD modelling of PR and QRS intervals in conscious dogs using standard safety pharmacology data.
    Bergenholm L; Collins T; Evans ND; Chappell MJ; Parkinson J
    J Pharmacol Toxicol Methods; 2016; 79():34-44. PubMed ID: 26780675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
    Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
    Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
    Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
    J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sodium and calcium channel block in unmasking the Brugada syndrome.
    Fish JM; Antzelevitch C
    Heart Rhythm; 2004 Jul; 1(2):210-7. PubMed ID: 15851155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.